Alpay, N. Et Al. 2013. Conversion from Calcineurin Inhibitors to Everolimus Resulted in Decrease of Serum TGF-beta and Urinary NGAL in Renal Transplant Recipients.. 13th American Transplant Congress (ATC) , (Washington, United States Of America), 545.

Alpay, N., Ozkok, A., Caliskan, Y., Akagun, T., Cinar, S., Deniz, G., ... Sariyar, M.(2013). Conversion from Calcineurin Inhibitors to Everolimus Resulted in Decrease of Serum TGF-beta and Urinary NGAL in Renal Transplant Recipients. . 13th American Transplant Congress (ATC) (pp.545). Washington, United States Of America

Alpay, N. Et Al. "Conversion from Calcineurin Inhibitors to Everolimus Resulted in Decrease of Serum TGF-beta and Urinary NGAL in Renal Transplant Recipients.," 13th American Transplant Congress (ATC), Washington, United States Of America, 2013

Alpay, N. Et Al. "Conversion from Calcineurin Inhibitors to Everolimus Resulted in Decrease of Serum TGF-beta and Urinary NGAL in Renal Transplant Recipients.." 13th American Transplant Congress (ATC) , Washington, United States Of America, pp.545, 2013

Alpay, N. Et Al. (2013) . "Conversion from Calcineurin Inhibitors to Everolimus Resulted in Decrease of Serum TGF-beta and Urinary NGAL in Renal Transplant Recipients.." 13th American Transplant Congress (ATC) , Washington, United States Of America, p.545.

@conferencepaper{conferencepaper, author={N. Alpay Et Al. }, title={Conversion from Calcineurin Inhibitors to Everolimus Resulted in Decrease of Serum TGF-beta and Urinary NGAL in Renal Transplant Recipients.}, congress name={13th American Transplant Congress (ATC)}, city={Washington}, country={United States Of America}, year={2013}, pages={545} }